SIRT or TACE in combination with Lenvatinib and PD-(L)1 inhibitor in high tumor burden hepatocellular carcinoma: a multicenter, retrospective, propensity score-matched study
SIRT 或 TACE 联合乐伐替尼和 PD-(L)1 抑制剂治疗高肿瘤负荷肝细胞癌：一项多中心、回顾性、倾向评分匹配研究
期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000004543
Huang, Jingjun; Niu, Huimin; Zhang, Hui; Cai, Mingyue; Wang, Zhiheng; Guo, Yongjian; Liang, Licong; Lin, Liteng; Yang, Tingqi; Huang, Jiabai; Liang, Yuchan; Guo, Zhaoxiong; Zhou, Jingwen; Huang, Wensou; Zhu, Kangshun
